Adjuvant Therapy for Gastric Cancer: Revisiting the Past to Clarify the Future

被引：19
作者：
Brooks, Gabriel A. [1 ]
Enzinger, Peter C. [1 ]
Fuchs, Charles S. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 19期
关键词：
LYMPH-NODE DISSECTION; PHASE-III TRIAL; CDH1; PROMOTER; CHEMOTHERAPY; SURGERY; D2; CAPECITABINE; METHYLATION; HIT; S-1;
D O I：
10.1200/JCO.2012.42.4069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2297 / 2299
页数：3
相关论文
共 15 条
[1]  
[Anonymous], J CLIN ONCOL S256
[2]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[3]  
ClinicalTrials.gov, 2001, DIFF GASTR ES JUNCT
[4]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[5]   Patient survival after D1 and D2 resections for gastric cancer:: long-term results of the MRC randomized surgical trial [J].
Cuschieri, A ;
Weeden, S ;
Fielding, J ;
Bancewicz, J ;
Craven, J ;
Joypaul, V ;
Sydes, M ;
Fayers, P .
BRITISH JOURNAL OF CANCER, 1999, 79 (9-10) :1522-1530
[6]   Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer [J].
Grady, WM ;
Willis, J ;
Guilford, PJ ;
Dunbier, AK ;
Toro, TT ;
Lynch, H ;
Wiesner, G ;
Ferguson, K ;
Eng, C ;
Park, JG ;
Kim, SJ ;
Markowitz, S .
NATURE GENETICS, 2000, 26 (01) :16-17
[7]   Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial [J].
Hartgrink, HH ;
van de Velde, CJH ;
Putter, H ;
Bonenkamp, JJ ;
Kranenbarg, EK ;
Songun, I ;
Welvaart, K ;
van Krieken, JHJM ;
Meijer, S ;
Plukker, JTM ;
van Elk, PJ ;
Obertop, H ;
Gouma, DJ ;
van Lanschot, JJB ;
Taat, CW ;
de Graaf, PW ;
von Meyenfeldt, MF ;
Tilanus, H ;
Sasako, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2069-2077
[8]   Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial [J].
Lee, Jeeyun ;
Lim, Do Hoon ;
Kim, Sung ;
Park, Se Hoon ;
Park, Joon Oh ;
Park, Young Suk ;
Lim, Ho Yeong ;
Choi, Min Gew ;
Sohn, Tae Sung ;
Noh, Jae Hyung ;
Bae, Jae Moon ;
Ahn, Yong Chan ;
Sohn, Insuk ;
Jung, Sin Ho ;
Park, Cheol Keun ;
Kim, Kyoung-Mee ;
Kang, Won Ki .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) :268-273
[9]   Gastric Cancer: Nagoya Is Not New York [J].
Macdonald, John S. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) :4348-4350
[10]   Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. [J].
Macdonald, JS ;
Smalley, SR ;
Benedetti, J ;
Hundahl, SA ;
Estes, NC ;
Stemmermann, GN ;
Haller, DG ;
Ajani, JA ;
Gunderson, LL ;
Jessup, JM ;
Martenson, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :725-730
12